MR spectroscopy imaging reveals effects of targeted treatment of mutant IDH1 gliomas. ScienceDaily . Retrieved May 16, 2025 from www.sciencedaily.com / releases / 2018 / 05 / 180518164050.htm ...

Proton magnetic resonance spectroscopy (MRS) of the brain can detect 2-hydroxyglutarate (2HG), the oncometabolite produced in neoplasms harboring a mutation in the gene coding for isocitrate ...

Using a novel imaging method, a Massachusetts General Hospital (MGH) research team is investigating the mechanisms behind a potential targeted treatment for a subtype of the deadly brains tumors ...

Assessment of low-grade glioma treatment response remains as much of a challenge as the treatment itself. Proton magnetic resonance spectroscopy (1H-MRS) and imaging were incorporated into a study ...

image: Three-dimensional magnetic resonance spectroscopy imaging reveals a decrease in tumor levels of 2-hydroxyglurate ... "Gliomas are aggressive, ...

As an example, human brain gliomas are among the most common and deadly pathologies of the brain, constituting ≃ 26% of all primary brain tumors and ≃ 81% of malignant primary brain tumors. Gliomas ...

Optic glioma is a brain tumor that grows slowly. Around 75% of diagnoses occur in children younger than 10 years old. Optic glioma accounts for approximately 5% of all childhood brain tumors.

Glioma is a type of brain cancer. It is the most common type of brain cancer in adults. There are different subtypes of glioma. Learn more.

An increasing amount of research shows that LAT1/4F2hc is over-expressed in a variety of human tumors. Is it useful as a prognostic marker and/or potential therapeutic target in gliomas?

During surgeries on 17 glioma patients, the researchers used the Raman probe in conjunction with magnetic resonance imaging, a conventional method surgeons use to find the borders of brain tumors.